Unlabelled: Essentials Microembolic signal (MES) is an independent predictor of stroke risk in patients. A rabbit model of cerebral microembolic signals was established. Therapeutic efficacy was demonstrated for aspirin and clopidogrel on microembolic signals. Potential translational value of this preclinical model of MES was demonstrated.
Summary: Objectives Cerebral microembolic signals (MESs) detected by transcranial Doppler (TCD) ultrasound constitute an independent predictor of stroke risk and prognosis. The aim of this study was to develop a novel preclinical model of MESs to facilitate translational research. Methods A clinical TCD ultrasound machine was used to detect MESs in the cerebral circulation of New Zealand White rabbits. Technical feasibility was assessed for the measurement of MESs in the middle cerebral artery (MCA) by TCD. FeCl3 -induced carotid arterial thrombosis was optimized for the generation of endogenous microemboli. Ascending doses of two antithrombotic agents (aspirin and clopidogrel) were evaluated individually and in combination for their effects on both arterial thrombosis and MESs in a 30% FeCl3 -induced carotid arterial thrombosis model, along with ex vivo functional assays. Results Dose-dependent FeCl3 -induced arterial thrombosis studies showed that 30% FeCl3 resulted in the most consistent and reproducible MESs in the MCA (3.3 ± 0.7 MESs h(-1) ). Ascending-dose studies showed that the effective doses for 50% inhibition (ED50 ) of thrombus formation, based on integrated blood flow and thrombus weight, respectively, were 3.1 mg kg(-1) and 4.2 mg kg(-1) orally for aspirin, and 0.3 mg kg(-1) and 0.28 mg kg(-1) orally for clopidogrel. The ED50 values for MES incidence were 12.7 mg kg(-1) orally for aspirin, and 0.25 mg kg(-1) orally for clopidogrel. Dual treatment with aspirin (5 mg kg(-1) ) and clopidogel (0.3 mg kg(-1) ) resulted in significant reductions in cerebral MESs (P < 0.05) as compared with monotherapy with either agent. Conclusions Our study demonstrated the successful establishment of the MES model in rabbits, and it may provide translational value for MESs and ischemic stroke research.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jth.13377 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Small subcortical ischemic infarction and other DWI lesions establish predictive model for MES.
Front Neurol
January 2025
Department of Neurosurgery, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Objective: The relationship between small subcortical ischemic infarction remains poorly characterized. Therefore, the present study aimed to investigate the association between artery-to-artery embolization and small subcortical infarctions.
Methods: This retrospective observational cross-sectional study enrolling 230 patients with acute middle cerebral artery (MCA) stroke classified into the microembolic signals-positive (MES+) and MES-negative (MES-) groups.
Microembolic signal detection in acute ischemic stroke: Clinical relevance and impact on treatment individualization-A narrative review.
Eur J Neurol
January 2025
Second Department of Neurology, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Background: Microembolic signals (MES) can be detected using transcranial Doppler (TCD) ultrasound in several clinical scenarios, including acute ischemic stroke (AIS). This narrative review aims to provide insights into their role in AIS patient management and outcomes.
Methods: The present narrative review consolidates current observational and randomized evidence on the prevalence and clinical relevance of MES in different AIS subtypes and settings.
Incidence of Microembolic Signals on Transcranial Doppler among Patients with Symptomatic Carotid Near Occlusion.
Eur J Vasc Endovasc Surg
November 2024
Institution of Clinical Sciences, Department of Neurosciences, Umeå University, Umeå, Sweden; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, Gothenburg, Sweden; Wallenberg Centre of Molecular Medicine, Umeå University, Umeå, Sweden.
Article Synopsis
- The study investigates the causes of ischaemic stroke in patients with symptomatic carotid near occlusion, focusing on whether an embolic or haemodynamic mechanism is responsible.
- Researchers compared the occurrence of microembolic signals (MES) in patients with symptomatic near occlusion, symptomatic conventional ≥ 50% stenosis, and asymptomatic ≥ 50% stenosis to determine the differences.
- Findings revealed that MES incidence was significantly higher in symptomatic near occlusion patients compared to both symptomatic conventional stenosis and asymptomatic cases, suggesting a potential link to increased embolic activity.
The immunopathology of coronary microembolization and the underlying inflammopathophysiological mechanisms.
Allergol Immunopathol (Madr)
November 2024
Department of ICU, Wuhan Wuchang Hospital, Wuhan, China;
In coronary microembolization, inflammatory cell infiltration, patchy necrosis, and extensive intra-myocardial hemorrhage are dominant, which induce myocardial dysfunction with clinical symptoms of chronic ischemic cardiomyopathy. Microembolization can lead to obstruction of the coronary microvessels and result in the micro-infarction of the heart. The inflammation and elevated expression of the tumor necrosis factor in cardiomyocytes and the activation of extracellular ERK are involved in initiating the inflammatory response mechanism.
View Article and Find Full Text PDFBezafibrate mitigates cardiac injury against coronary microembolization by preventing activation of p38 MAPK/NF-κB signaling.
Aging (Albany NY)
October 2024
Department of Cardiology, Chongyi People’s Hospital, Ganzhou 341399, Jiangxi Province, China.
Article Synopsis
- The study looked at how a drug called Bezafibrate can help protect the heart from damage caused by coronary microembolization (CME), which is when small blood clots block tiny heart blood vessels.
- Researchers tested Bezafibrate on rats with heart damage and found that it improved heart function, reduced markers of injury, and lowered inflammation.
- Bezafibrate was also shown to prevent heart cell death and act through certain biological pathways, suggesting it could be a helpful treatment for heart problems related to CME.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!